Latest Articles and Analysis

Employers can advance health equity through inclusive benefits design and quality provider networks.

US Trans Survey provides critical data on transgender healthcare, discrimination, and social determinants.

Q4 2022 Watch: HHS renewed opioid emergency; CANN launched monkeypox project; HEPLISAV-B hepatitis B vaccine covered.

Louisiana and Washington HCV subscription models save millions but fail elimination goals; cost alone isn't the barrier.

Provider language shows negative bias toward Black patients at 2.5x rate, undermining care engagement.

White House releases federal implementation plan with 380+ action items for National HIV/AIDS Strategy.

Stigma drives opposition to harm reduction programs like safe consumption sites despite strong evidence.

Innovative HIV medications available but inaccessible: payer barriers block Cabenuva and Apretude access.

Community-based low-barrier HCV treatment for PWID significantly improves liver health outcomes.

CANN roundtable examines COVID-19 impacts on public health advocacy, Medicaid expansion, and HIV programs.

Restrictions on abortion and transgender care represent broader attacks on medication access as human right.

Medication abandonment disproportionately affects Black patients; PrEP users 41% more likely to abandon.

MAT Act removes X-waiver requirements, expanding buprenorphine access especially in rural communities.

CANN announces 2022 organizational changes including rebranding and launching the 340B Action Center.

CANN reflects on 2021 advocacy spanning 340B drug pricing, HIV, hepatitis C, and substance use disorder policy.

Global Fund report shows COVID-19 reduced HIV/HCV program efficacy while South Africa tripled ART coverage.

Analysis of hepatitis B vaccine efficacy and revaccination protocols for people living with HIV.

COVID-19 strains public health efforts addressing HIV outbreaks, diverting resources from the domestic epidemic.

Post-PHE planning for Medicaid redetermination: extended timelines and navigator support for safety net care.

Study explores social-spatial networks and HIV/HCV diagnosis rates among homeless and injection drug users.